Biomarker Jeopardy

J Adv Pract Oncol. 2022 Apr;13(3):292-297. doi: 10.6004/jadpro.2022.13.3.22. Epub 2022 May 23.

Abstract

In the popular Biomarker Jeopardy session, Sandra E. Kurtin, PhD, ANP-C, AOCN®, Alyssa Henglefelt, PharmD, BCOP, and Haleigh Mistry, MS, PA-C, paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure common biomarkers, and discussed guidelines for biomarker testing.